Testing effectiveness (Phase 2)WithdrawnNCT00601289
What this trial is testing
Temozolomide in Treating Patients With Invasive Pituitary Tumors
Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Showing 2 of 2 results